微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -3.5% | -622.39% | -629.17% | 121/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.48% | -154.55% | 81.89% | 109/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -2.65% | 46.03% | -609.62% | 105/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 0.52% | 4% | -22.39% | 98/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.67% | 452.63% | -23.86% | 92/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.88% | 319.05% | 117.92% | 75/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -4.91% | -165.03% | -1082% | 114/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.5% | -94.85% | 363.16% | 105/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.19% | -102.19% | -190.48% | 108/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.21% | -97.51% | -97.22% | 100/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.55% | -2.83% | -22.25% | 53/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 9.71% | 3.3% | 12.12% | 29/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 8.66% | 41.97% | 2.49% | 13/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 8.45% | 113.92% | 8.75% | 3/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 7.77% | -61.8% | -17.34% | 75/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 9.4% | -45.57% | 54.1% | 58/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.1% | -49.04% | 54.43% | 64/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.95% | -44.05% | -80.58% | 39/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 20.34% | -66.42% | 17.78% | 39/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.27% | -70.42% | 44.28% | 36/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 11.97% | -74.65% | 69.55% | 39/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 7.06% | -30.51% | -88.35% | 23/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 60.58% | 351.42% | 3.75% | 14/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 58.39% | 153.98% | 23.68% | 8/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 47.21% | 877.43% | 251.79% | 11/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 13.42% | 9.37% | 9.37% | 59/141 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2018-12-31 | 12.27% | -27.74% | 154.04% | 59/141 | 14.23% | 健尔康 | 84.09% | 行业排名> |
| 2018-06-30 | 4.83% | -68.41% | -71.55% | 27/141 | 4.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2017-12-31 | 16.98% | -39.36% | 67.13% | 40/141 | 14.51% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-03-31 | 10.16% | 2% | -63.71% | 2/141 | 2.74% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 28% | 14.33% | 21.79% | 15/141 | 16.44% | 安旭生物 | 48.71% | 行业排名> |
| 2016-09-30 | 22.99% | 2% | 50.36% | 3/141 | 8.86% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2016-06-30 | 15.29% | 2% | -37.57% | 5/141 | 6.35% | *ST明德 | 14.54% | 行业排名> |